XPhyto signs transformative acquisition agreement with 3a-diagnostics
Enter hi-tech biosensor market and expand its diagnostic product portfolio
22-Jul-2021 -
XPhyto Therapeutics Corp. announced that it has signed a definitive agreement for the acquisition of 3a-diagnostics GmbH, Frickenhausen, Germany. Pursuant to the definitive agreement, XPhyto will acquire all of the outstanding shares of 3a for EUR 400,000, to be paid immediately, and EUR 3.5 ...
acquisitions
biosensors
diagnostics